Who
Ezra M. Friedberg
Director
Company insider
Files Form 4 as: Director, Pelthos Therapeutics; Director, Kalobios Pharmaceuticals.
In numbers
- Trades disclosed
- 41
- Buys
- 1
- Sells
- 5
- Bought
- $100K
- Sold
- $360K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 13 Sep 2016
- Last trade
- 2 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 6 Oct 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $12K558 at $20.72 | filing |
| 2 Jul 2026filed 7 Jul 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $14K534 at $26.03 | filing |
| 2 Jul 2026filed 7 Jul 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $65624 at $27.33 | filing |
| 2 Jul 2026filed 7 Jul 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $14K534 at $26.03 | filing |
| 2 Jul 2026filed 7 Jul 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $65624 at $27.33 | filing |
| 15 Jun 2026filed 17 Jun 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $6,076224 at $27.12 | filing |
| 15 Jun 2026filed 17 Jun 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1,64859 at $27.94 | filing |
| 15 Jun 2026filed 17 Jun 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $6,075224 at $27.12 | filing |
| 15 Jun 2026filed 17 Jun 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1,64859 at $27.94 | filing |
| 14 May 2026filed 18 May 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $3,889144 at $27.01 | filing |
| 14 May 2026filed 18 May 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $3,889144 at $27.01 | filing |
| 2 Apr 2026filed 6 Apr 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $6,010293 at $20.51 | filing |
| 2 Apr 2026filed 6 Apr 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $5,661265 at $21.36 | filing |
| 2 Apr 2026filed 6 Apr 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $6,009293 at $20.51 | filing |
| 2 Apr 2026filed 6 Apr 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $5,660265 at $21.36 | filing |
| 25 Nov 2025filed 26 Nov 2025 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $168K5,999 at $28.00 | filing |
| 25 Nov 2025filed 26 Nov 2025 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $56K2,000 at $28.14 | filing |
| 25 Nov 2025filed 26 Nov 2025 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $291 at $28.50 | filing |
| 25 Nov 2025filed 26 Nov 2025 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $56K2,000 at $28.01 | filing |
| 2 Jul 2025filed 1 Apr 2026 | PTHS Pelthos TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —19,108 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.